Journal of Clinical Medicine
Renoprotective vs. Antihypertensive Dosing of Renin–Angiotensin System Inhibitors in Chronic Kidney Disease: Analysis of Summary of Product Characteristics of Medicinal Products Authorized in Poland
Par Marta Maciejczyk, Anna Maria Dworakowska et Magdalena Bujalska-Zadrożny.
Contenu en anglais
Résumé
Introduction
Renin–angiotensin system inhibitors are central to antihypertensive and nephroprotective treatment in chronic kidney disease. However, renal dosing information in Summaries of Product Characteristics (SmPCs) may differ between products and may not reflect current kidney function assessment.